Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2016 | 08-2015 | 08-2014 | 08-2013 | 08-2012 | |
| Sales | 3,839,987 | 3,457,400 | 3,345,946 | 3,186,143 | 3,215,234 |
| Cost of Goods | 3,362,053 | 3,003,613 | 2,914,142 | 2,781,892 | 2,826,212 |
| Gross Profit | 477,934 | 453,787 | 431,804 | 404,251 | 389,022 |
| Operating Expenses | 422,867 | 405,558 | 443,555 | 383,173 | 373,165 |
| Operating Income | 55,067 | 48,229 | -11,751 | 21,078 | 15,857 |
| Interest Expense | 16,727 | 14,807 | 18,881 | 22,338 | 27,028 |
| Other Income | 30,569 | 26,033 | -54,412 | 36,288 | 54,597 |
| Pre-tax Income | 68,909 | 59,455 | -85,044 | 35,028 | 43,426 |
| Income Tax | 17,239 | 16,329 | 5,727 | 10,736 | 13,143 |
| Net Income Continuous | 51,670 | 43,126 | -90,771 | 24,292 | 30,283 |
| Net Income | $51,670 | $43,126 | $-90,771 | $24,292 | $30,283 |
| EPS Basic Total Ops | 0.11 | 0.09 | -0.19 | 0.05 | 0.06 |
| EPS Basic Continuous Ops | 0.11 | 0.09 | -0.19 | 0.05 | 0.06 |
| EPS Diluted Total Ops | 0.11 | 0.09 | -0.19 | 0.05 | 0.06 |
| EPS Diluted Continuous Ops | 0.11 | 0.09 | -0.19 | 0.05 | 0.06 |
| EBITDA(a) | $112,079 | $94,643 | $-47,918 | $75,535 | $90,619 |